Announcements Trials
Browse Landscape

Phase

Phase NA 28Phase 3 5Phase 2 4Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Cancer Pain 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Electroacupuncture × Clear all
NCT07489625 2026-03-24

Hydromorphone With Electroacupuncture and Ear Acupoint Pressing for Refractory Cancer Pain

Qinghai Red Cross Hospital

Phase EARLY_PHASE1 Not yet recruiting
30 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡